Management of Atypical and Anaplastic Meningiomas

Simon Buttrick, Ashish H. Shah, Ricardo J Komotar, Michael E. Ivan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Meningiomas are the most prevalent primary tumor of central nervous system origin and, although most neoplasms are benign, a small proportion exemplifies an aggressive profile characterized by high recurrence rates, pleomorphic histology, and overall resistance to standard treatment. Standard initial therapy for malignant meningiomas includes maximal safe surgical resection followed by focal radiation in certain cases. The role for chemotherapy during recurrence of these aggressive meningiomas is less clear. Prognosis is poor and recurrence of malignant meningiomas is high. This article provides an overview of atypical and anaplastic malignant meningiomas, their treatment, and ongoing research for more effective treatments.

Original languageEnglish (US)
Pages (from-to)239-247
Number of pages9
JournalNeurosurgery Clinics of North America
Volume27
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Meningioma
Recurrence
Central Nervous System Neoplasms
Therapeutics
Histology
Radiation
Drug Therapy
Research
Neoplasms

Keywords

  • Anaplastic meningioma
  • Atypical meningioma
  • Chemotherapy
  • Malignant meningioma
  • Malignant meningioma
  • Radiation therapy
  • Recurrence

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Management of Atypical and Anaplastic Meningiomas. / Buttrick, Simon; Shah, Ashish H.; Komotar, Ricardo J; Ivan, Michael E.

In: Neurosurgery Clinics of North America, Vol. 27, No. 2, 01.04.2016, p. 239-247.

Research output: Contribution to journalArticle

Buttrick, Simon ; Shah, Ashish H. ; Komotar, Ricardo J ; Ivan, Michael E. / Management of Atypical and Anaplastic Meningiomas. In: Neurosurgery Clinics of North America. 2016 ; Vol. 27, No. 2. pp. 239-247.
@article{d03648c8d544464783c21f09706e4f7f,
title = "Management of Atypical and Anaplastic Meningiomas",
abstract = "Meningiomas are the most prevalent primary tumor of central nervous system origin and, although most neoplasms are benign, a small proportion exemplifies an aggressive profile characterized by high recurrence rates, pleomorphic histology, and overall resistance to standard treatment. Standard initial therapy for malignant meningiomas includes maximal safe surgical resection followed by focal radiation in certain cases. The role for chemotherapy during recurrence of these aggressive meningiomas is less clear. Prognosis is poor and recurrence of malignant meningiomas is high. This article provides an overview of atypical and anaplastic malignant meningiomas, their treatment, and ongoing research for more effective treatments.",
keywords = "Anaplastic meningioma, Atypical meningioma, Chemotherapy, Malignant meningioma, Malignant meningioma, Radiation therapy, Recurrence",
author = "Simon Buttrick and Shah, {Ashish H.} and Komotar, {Ricardo J} and Ivan, {Michael E.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.nec.2015.11.003",
language = "English (US)",
volume = "27",
pages = "239--247",
journal = "Neurosurgery Clinics of North America",
issn = "1042-3680",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Management of Atypical and Anaplastic Meningiomas

AU - Buttrick, Simon

AU - Shah, Ashish H.

AU - Komotar, Ricardo J

AU - Ivan, Michael E.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Meningiomas are the most prevalent primary tumor of central nervous system origin and, although most neoplasms are benign, a small proportion exemplifies an aggressive profile characterized by high recurrence rates, pleomorphic histology, and overall resistance to standard treatment. Standard initial therapy for malignant meningiomas includes maximal safe surgical resection followed by focal radiation in certain cases. The role for chemotherapy during recurrence of these aggressive meningiomas is less clear. Prognosis is poor and recurrence of malignant meningiomas is high. This article provides an overview of atypical and anaplastic malignant meningiomas, their treatment, and ongoing research for more effective treatments.

AB - Meningiomas are the most prevalent primary tumor of central nervous system origin and, although most neoplasms are benign, a small proportion exemplifies an aggressive profile characterized by high recurrence rates, pleomorphic histology, and overall resistance to standard treatment. Standard initial therapy for malignant meningiomas includes maximal safe surgical resection followed by focal radiation in certain cases. The role for chemotherapy during recurrence of these aggressive meningiomas is less clear. Prognosis is poor and recurrence of malignant meningiomas is high. This article provides an overview of atypical and anaplastic malignant meningiomas, their treatment, and ongoing research for more effective treatments.

KW - Anaplastic meningioma

KW - Atypical meningioma

KW - Chemotherapy

KW - Malignant meningioma

KW - Malignant meningioma

KW - Radiation therapy

KW - Recurrence

UR - http://www.scopus.com/inward/record.url?scp=84961200294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961200294&partnerID=8YFLogxK

U2 - 10.1016/j.nec.2015.11.003

DO - 10.1016/j.nec.2015.11.003

M3 - Article

C2 - 27012388

AN - SCOPUS:84961200294

VL - 27

SP - 239

EP - 247

JO - Neurosurgery Clinics of North America

JF - Neurosurgery Clinics of North America

SN - 1042-3680

IS - 2

ER -